Compounds > cefotetan
Page last updated: 2024-08-23

cefotetan and Bacteroides Infections

cefotetan has been researched along with Bacteroides Infections in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's6 (54.55)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishino, T; Saito, M; Saito, T; Shibata, K; Tanino, T; Yano, K1
Brook, I4
Adams, RB; May, AK; Pruett, TL; Rosenlof, LK; Sawyer, RG1
Alfonso, B; Ehrenkranz, NJ1
Farmer, SG; Grossmeyer, TJ1
Encarnacion, C; Mehta, RN; Nehra, A1
Marradi, C; Nardone, A; Nespoli, A; Padalino, P1
Citron, DM; Goldstein, EJ1

Other Studies

11 other study(ies) available for cefotetan and Bacteroides Infections

ArticleYear
Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:2

    Topics: Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefazolin; Cefmetazole; Cefotetan; Cephamycins; Escherichia coli Infections; Fusobacterium Infections; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred Strains; Serratia marcescens

1984
Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20 Suppl 2

    Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Cephamycins; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Penicillins; Peritoneal Diseases; Sulbactam

1995
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    The American surgeon, 1995, Volume: 61, Issue:8

    Topics: Abscess; Amphotericin B; Animals; Bacteroides fragilis; Bacteroides Infections; Candida albicans; Candidiasis; Cefotetan; Cefoxitin; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred BALB C; Peritoneal Diseases; Peritonitis; Survival Rate

1995
Increased resistance to cefoxitin and cefotetan among Bacteroides fragilis isolates from abdominal sources in patients undergoing surgery.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:6

    Topics: Abdomen; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Humans; Surgical Wound Infection

1993
Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16 Suppl 4

    Topics: Bacteria, Anaerobic; Bacterial Infections; Bacteroides; Bacteroides Infections; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests

1993
Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16 Suppl 4

    Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Drug Evaluation, Preclinical; Escherichia coli Infections; Male; Mice

1993
Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7

    Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus

1993
Bacteroides fragilis arthritis in a patient with sickle cell disease.
    The American journal of medicine, 2001, Volume: 111, Issue:2

    Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Arthritis, Infectious; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Clavulanic Acid; Diagnosis, Differential; Humans; Male; Metronidazole; Ticarcillin; Treatment Outcome

2001
Cefotetan versus clindamycin/tobramycin association in mixed aero-anaerobic peritonitis in rats.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Acute-Phase Proteins; Animals; Bacteroides Infections; Cefotetan; Clindamycin; Drug Therapy, Combination; Escherichia coli Infections; Liver; Male; Muscles; Peritonitis; Proteins; Rats; Rats, Inbred Strains; Tobramycin

1987
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    The Journal of infectious diseases, 1989, Volume: 160, Issue:4

    Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam

1989
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Journal of clinical microbiology, 1988, Volume: 26, Issue:11

    Topics: Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Ceftizoxime; Humans; Microbial Sensitivity Tests; Periodicity

1988